Controls-LS exhibited significant differences compared to COVID-19+ cases in various immune cell subsets, including T and B lymphocytes, CD4 and CD8 maturation markers, and markers of cellular senescence and inflammation. The gene discussed is CD8A; the disease is COVID-19.